{
    "2019-11-01": [
        [
            {
                "time": "2019-11-01",
                "original_text": "有65家公司获重要股东增减持 延安必康已被连续减持134次",
                "features": {
                    "keywords": [
                        "重要股东",
                        "增减持",
                        "延安必康",
                        "连续减持"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-11-01",
                "original_text": "四大基金争夺冠军 谨防散户沦为基金砸盘牺牲者",
                "features": {
                    "keywords": [
                        "基金",
                        "冠军",
                        "散户",
                        "砸盘"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-11-01",
                "original_text": "云南白药(000538.SZ)截至10月末累计耗资2.45亿元回购0.26%股份",
                "features": {
                    "keywords": [
                        "云南白药",
                        "回购",
                        "股份"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-11-01",
                "original_text": "【IPO追踪】市场消息指中国抗体制药(3681-HK)国际配售获数倍认购",
                "features": {
                    "keywords": [
                        "IPO",
                        "中国抗体制药",
                        "国际配售",
                        "认购"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-11-01",
                "original_text": "牛市早报｜5G商用正式启动，美股全线大跌道指跌0.52%",
                "features": {
                    "keywords": [
                        "5G",
                        "商用",
                        "美股",
                        "道指",
                        "下跌"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-11-01",
                "original_text": "巨丰数据赢｜北上资金流入力度加强 两股再现“价值洼地”",
                "features": {
                    "keywords": [
                        "北上资金",
                        "流入",
                        "价值洼地"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-11-01",
                "original_text": "医药生物板块四季度行情如何？多家机构看好走势",
                "features": {
                    "keywords": [
                        "医药生物",
                        "四季度",
                        "机构",
                        "看好"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}